Tag: coveted
AstraZeneca’s Brilinta won its coveted stroke-prevention nod. Will it be enough...
A few months ago, AstraZeneca’s Brilinta added a new U.S. indication to reduce the chance of a first heart attack or stroke in certain...
Watch out, Merck: FDA grants Regeneron, Sanofi’s Libtayo priority review for...
One month after Regeneron and Sanofi posted impressive data from a phase 3 trial of their PD-1 inhibitor Libtayo in first-line non-small cell lung...